US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
FDA Restructures its Food Resources Although there were a number of significant new regulations, the most significant food ...
T he U.S. Food and Drug Administration (FDA) banned the use of Red Dye No.3 in foods and has given drug manufacturers until ...
STATEN ISLAND, N.Y. — A popular brand of cookies has been recalled across the United States for containing “life-threatening' allergens, according to the Food and Drug Administration (FDA).
There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of ...
Now that the US Food and Drug Administration has banned red dye No. 3, many people are criticizing or questioning the safety ...
Zacks.com on MSN1d
FDA Expands Label of AZN's Enhertu for New Breast Cancer IndicationAstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback